pruritus

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)

Completed
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg
  • Placebo
  • Fort Smith, Arkansas
  • +35 more
Aug 1, 2022

Pruritus Trial in United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)

Completed
  • Pruritus
  • 5 mg Serlopitant Tablets
  • Matching Placebo Tablets
  • Hot Springs, Arkansas
  • +40 more
May 18, 2021

Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)

Completed
  • Pruritus
  • Prurigo Nodularis
  • 5mg Serlopitant Tablets
  • Placebo Tablets
  • Birmingham, Alabama
  • +48 more
May 18, 2021

Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)

Terminated
  • Pruritus
  • +3 more
  • 5 mg Serlopitant Tablets
  • Birmingham, Alabama
  • +84 more
May 18, 2021

Pruritus, Atopic Dermatitis Trial in United States (Serlopitant High Dose, Placebo Oral Tablet, Serlopitant Low Dose)

Completed
  • Pruritus
  • Atopic Dermatitis
  • Serlopitant High Dose
  • +2 more
  • Anniston, Alabama
  • +51 more
May 18, 2021

Dermatitis, Atopic, Pruritus, Dermatitis Eczema Trial in Canada, United States (ASN008 TG, Placebo TG)

Completed
  • Dermatitis, Atopic
  • +2 more
  • ASN008 TG
  • Placebo TG
  • Cortland, New York
  • +4 more
May 27, 2020

Pruritus, Psoriasis Vulgaris Trial in United States (SNA-120, Vehicle)

Completed
  • Pruritus
  • Psoriasis Vulgaris
  • Scottsdale, Arizona
  • +37 more
Feb 4, 2019

Atopic Dermatitis, Pruritus Trial in High Point (RD047-26)

Completed
  • Atopic Dermatitis
  • Pruritus
  • RD047-26
  • High Point, North Carolina
    Dermatology Consulting Services
May 29, 2012